COVID-19 VACCINATIONS: If, in addition to indemnity for your main employment, you would like cover for delivering COVID-19 Vaccinations please apply for our standalone extension Apply Today

Home  »   National Association of Women PharmacistsLatest News   »   PDA and NAWP respond to the DHSC’s call for evidence on a strategy for women’s health

PDA and NAWP respond to the DHSC’s call for evidence on a strategy for women’s health

The PDA and NAWP (National Association of Women Pharmacists) have issued a joint response to the DHSC (Department of Health and Social Care)’s call for evidence to support the development of a Women’s Health Strategy in England.

Tue 8th June 2021 The PDA

The response highlights several opportunities which the PDA and NAWP believe could improve health for women and should form part of the government’s future plans.

Key points from the response include that the workplace needs to be much more responsive to women’s health concerns and that company sickness policies need to be appropriately supportive and effective. The PDA and NAWP have highlighted the need to consider how employers can meet their business or operational needs whilst addressing their duty of care in relation to their workforce, and maximising health and wellbeing overall in the workplace.

As a major employer of women in the UK, the NHS has a role to play in the improvement of the health of its workforce and the PDA and NAWP suggest that both health promotion campaigns and education around women’s health should be integrated within the NHS. This would potentially have a sizeable impact both on women employed in the organisation, as well as those that are cared for and treated by its staff.

Recognising that opportunities to improve women’s health go much further beyond health and social care, both the PDA and NAWP have called on the government to take a multi-departmental approach, as there are other factors that impact on this important area. The Women’s Health Strategy also needs to look outside of gender, and seek to address other disparities, such as racial bias in healthcare provision which may have an impact on women of colour.

Fundamentally, the response highlights that pharmacists have a unique opportunity to open conversations with women through their practice and to make important and timely interventions. More could be done to formalise this and maximise the skills and opportunities that pharmacists have to widen access to healthcare for women resulting in improving health outcomes.

Naina Chotai, President of NAWP, said, “We welcome the opportunity to feed in evidence around the development of the Women’s Health Strategy and we will continue to highlight the role that pharmacists play across all settings in improving the health of the nation, including women. The PDA and NAWP hope that the government takes this opportunity to develop a sustainable and tangible strategy which will improve women’s health across all generations.”


thumbnail of DHSC Women’s Health Strategy_PDA_NAWP_May 2021_FINAL

Related links

Not yet a PDA member?

If you have not yet joined the PDA, we encourage you to join today and encourage your colleagues to do the same.

Membership is FREE to pharmacy students, pre-regs and for the first three months of being provisionally registered/newly qualified.


Read about our key member benefits here.







The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)